Nia Therapeutics update: June 2021

  • Demonstrated proof of concept efficacy in patients with a history of traumatic brain injury
  • Completed development of our bench-top prototype and confirmed its cybersecurity architecture with FDA
  • Received a $1M subcontract from US Army and expanded our engineering team
  • Graduated from the Creative Destruction Lab accelerator and won the INVEST Precision Medicine pitch competition

--

--

--

CEO at Nia Therapeutics. Developing neural interfaces to restore memory after brain injury.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Artificial Intelligence and Machine Learning eBook Bundle

Why human HR should not fear AI-powered bots

Pretty soon, humans won’t die at all.

Top 10 Amazing Enterprise AI Platforms Available In 2022

10 Alarming Predictions for Deep Learning in 2018

Greed, Fear, Game Theory and Deep Learning

AWS Innovate in a Flash(AI

Artificial Intelligence (AI) in Health Sector

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dan Rizzuto

Dan Rizzuto

CEO at Nia Therapeutics. Developing neural interfaces to restore memory after brain injury.

More from Medium

Fastbill’s Exit to Canada Based Unicorn FreshBooks

Alkira and Aruba Networks: Where SD-WAN Meets Cloud

Anomaly Detection in AWS Lambda using Amazon DevOps Guru’s ML-powered insights

HYBE Corporation Asset Tokenization Strategy